U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07475923) titled 'Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)' on March 13.
Brief Summary: To learn about changes in ctDNA during the diagnosis, treatment, and post-treatment surveillance of EBC.
Study Start Date: Aug. 26, 2026
Study Type: OBSERVATIONAL
Condition:
Molecular Surveillance
Breast Cancer
ctDNA
MRD
Observational Study
Intervention:
DIAGNOSTIC_TEST: Blood draw for the laboratory assessment
Blood will be drawn up to every cycle during neoadjuvant treatment
DRUG: Neoadjuvant tr...